Passive movement therapy in patients with moderate to severe paratonia; study protocol of a randomised clinical trial (ISRCTN43069940)

Johannes S M Hobbelen, Frans R J Verhey, Jacobus H J Bor, Rob A de Bie, Raymond T C M Koopmans, Johannes S M Hobbelen, Frans R J Verhey, Jacobus H J Bor, Rob A de Bie, Raymond T C M Koopmans

Abstract

Background: Paratonia, a form of hypertonia, is associated with loss of mobility and with the development of contractures especially in the late stages of the dementia. Passive movement therapy (PMT) currently is the main physiotherapeutic intervention. General doubt about the beneficial effects of this widely used therapy necessitates a randomised clinical trial (RCT) to study the efficacy of PMT on the severity of paratonia and on the improvement of daily care.

Methods/design: A RCT with a 4-week follow-up period. Patients with dementia (according to the DSM-IV-TR Criteria) and moderate to severe paratonia are included in the study after proxy consent. By means of computerised and concealed block randomisation (block-size of 4) patients are included in one of two groups. The first group receives PMT, the second group receives usual care without PMT. PMT is given according to a protocol by physical therapist three times a week for four weeks in a row. The severity of paratonia (Modified Ashworth scale), the severity of the dementia (Global Deterioration Scale), the clinical improvement (Clinical Global Impressions), the difficulty in daily care (Patient Specific Complaints) and the experienced pain in daily care of the participant (PACSLAC-D) is assessed by assessors blind to treatment allocation at baseline, after 6 and 12 treatments. Success of the intervention is defined as a significant increase of decline on the modified Ashworth scale. The 'proportion of change' in two and four weeks time on this scale will be analysed. Also a multiple logistic regression analysis using declined/not declined criteria as dependent variable with correction for relevant confounders (e.g. stage of dementia, medication, co-morbidity) will be used.

Discussion: This study is the first RCT of this size to gain further insight on the effect of passive movement therapy on the severity of paratonia.

Trial registration: Current Controlled Trials ISRCTN43069940.

References

    1. Dupré E. Débilité mentale et débilité motrice associées. Rev Neurol. 1910;20:54–56.
    1. Franssen EH, Kluger A, Torossian CL, Reisberg B. The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline. Arch Neurol. 1993;50:1029–1039.
    1. Hobbelen J, de Bie R, van Rossum E. Effect of passive movement on severity of paratonia:a partially blinded, randomized clinical trial. Nederlands Tijdschrift voor Fysiotherapie. 2003;113:132–137.
    1. Paulson G, Gottlieb G. Development reflexes: the reappearance of foetal and neonatal reflexes in aged patients. Brain. 1968;91:37–52. doi: 10.1093/brain/91.1.37.
    1. Souren LE, Franssen EH, Reisberg B. Neuromotor changes in Alzheimer's disease: implications for patient care. J Geriatr Psychiatry Neurol. 1997;10:93–98.
    1. Hobbelen JSM, Koopmans RTCM, Verhey FRJ, Habraken KM, de Bie RA. Diagnosing paratonia in the demented elderly; reliability and validity of the paratonia assessment instrument (PAI) International Psychogeriatrics. 2007.
    1. Gajdosik RL. Passive extensibility of skeletal muscle: review of the literature with clinical implications. Clin Biomech (Bristol, Avon) 2001;16:87–101. doi: 10.1016/S0268-0033(00)00061-9.
    1. Van Wingerden BAM. Mobilization. Connective tissue in rehabilitation. 1997. pp. 197–241.
    1. Leemrijse C, de Boer M, Ribbe M. Paramedic care in Dutch nursing homes; explaining the differences? Utrecht: NIVEL. 2005.
    1. Arnts W, Van Oostwaard P, Rooyakkers A. Physiotherapy treatment for paratonia. Nederlands Tijdschrift voor Fysiotherapie. 1989;99:216–220.
    1. Pomeroy V. Immobility and severe dementia: when is phyiotherapy treatment appropriate. Clinical Rehabilitation. 1994;8:226–232.
    1. Brooks SV, Faulkner JA. The magnitude of the initial injury induced by stretches of maximally activated muscle fibres of mice and rats increases in old age. J Physiol. 1996;497:573–580.
    1. Hobbelen JS, Koopmans RT, Verhey FR, Van Peppen RP, de Bie RA. Paratonia: a delphi procedure for consensus definition. J Geriatr Phys Ther. 2006;29:50–56.
    1. Waardenburg H, Elvers W, Van Vechgel F, Oostendorp R. Can paratonia be measured reliably? Evaluation of the reliability of a visual analogue scale and the modified tonus scale of Ashworth for measuring paratonia. Nederlands Tijdschrift voor Fysiotherapie. 1999;102:30–35.
    1. Fuchs-Lacelle S, Hadjistavropoulos T. Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC) Pain Manag Nurs. 2004;5:37–49. doi: 10.1016/j.pmn.2003.10.001.
    1. Zwakhalen SM, Hamers JP, Abu-Saad HH, Berger MP. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatr. 2006;6:3. doi: 10.1186/1471-2318-6-3.
    1. Zwakhalen SM, Hamers JP, Berger MP. Improving the clinical usefulness of a behavioural pain scale for older people with dementia. J Adv Nurs. 2007;58:493–502. doi: 10.1111/j.1365-2648.2007.04255.x.
    1. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of psychiatry. 1982;139:1136–1139.
    1. Medicines NCO Guidelines for ATC Classification. Oslo: WHO Collaborating Center for Drugs Statistics Methodology. 1990.
    1. Twisk JWR. Applied longitudinal data analysis for epidemiology: a practical guide. Cambridge: Cambridge University Press; 2003.
    1. Hendriks HJM, Bekkering GE, van Ettekoven H, Brandsma JW, van der Wees PJ, de Bie RA. Development and implementation of national practice guidelines: a prospect for continuous quality improvement in physiotherapy. Physiotherapy. 2000;86:535–547. doi: 10.1016/S0031-9406(05)60988-1.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe